EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
- Photo Info
- Download
- 2 additional media items
One document
CanSERV Call on Service Provision
EUR 1.000.000 EU funding available to cancer researchers to accelerate the development of individualised cancer treatments
Graz, 12 October 2023: From today, scientists can apply for free access to more than 400 cancer research services addressing the needs of the entire oncological research pipeline. The services range from basic to clinical science and offer a wide range of possible service combinations. These are made available through Calls for Proposals released by the EU-funded collaborative project canSERV, the largest European-wide consortium of research infrastructures. Today, the international consortium has published the Open Call for “Translational Service Provision” with a tentative budget of EURO 1.0 Mio. Scientific proposals with a relevant oncological focus can be submitted by the 4th of January 2024 via the canSERV project website and the unique Common Access Management System.
Open Call for Transnational Service Provision
As part of a concerted strategy to tackle the challenges of cancer, canSERV offers more than 400 customised world-class oncology technologies and state-of-the-art training to cancer researchers worldwide.
The EU Cancer Mission and canSERV
Combined with the shift towards interdisciplinary approaches in both cancer research and cancer treatment, the European Union strives to further accelerate progress towards fighting and preventing cancer in the next decades as outlined in the 2021 EU Cancer Mission and Europe’s Beating Cancer Plan. To contribute to this goal, it must be ensured that Europe’s cancer research community, its industry as well as European citizens have access to the required tools and services.
Prof. Jens K. Habermann, Director General of BBMRI-ERIC, that is coordinating canSERV, to this project call:
"canSERV bundles research infrastructures, oncology experts, and patient associations to provide the cancer community with the facilities, resources and services needed in order to enhance personalised treatment approaches. The grants offer a unique chance for cross-domain, interdisciplinary research proposals to come closer to this goal.”
Providing academia and industry with customised research services
Following the success of the first Call on “Advancing Personalised Oncology”, canSERV now invites applications covering the entire range of the oncology developmental pipeline – for a particular service or a combination; supporting discoveries in fundamental research to translational science and personalised oncology.
canSERV welcomes excellent research applications addressing at least one of the four strategic goals of the Cancer Mission:
- Understanding of Cancer
- Prevention and Early Detection
- Diagnosis and treatment
- Quality of life for patients and their families
Researchers from academia, industry and SMEs may apply for several services including: i) disease models, ii) cutting-edge imaging and structural biology technologies, iii) biomarker research and development, iv) new therapeutic solutions, v) complex clinical trial design and support, vi) personalised oncology implementation pipelines and recommendations and vii) regulatory support and tools to analyse the socio-economic dimension of research activities.
Submission details for applicants
Launch date: Thursday, 12 October 2023.
Submission deadline: 4 January 2024, 2pm CET.
The applications will be reviewed by an international, independent review panel!
The tentative budget for this first call is 1.0 Mio. EURO. For more information and Call text, please visit our CanSERV project website: www.canSERV.eu/Calls
About European Research Infrastructures
European Research Infrastructures (RIs) are organisations that enable the research community to use specific facilities, resources and services to accelerate scientific achievements and promote sustainable research. Being at the core of the knowledge triangle research, education and innovation, RIs have emerged over the past decade as valuable structures to accelerate research and innovation in Europe. In this project, the European Life Science research infrastructures focus on oncology research and innovation and provide support from basic science up to clinical translation (from bench to bedside) to foster personalised medicine for cancer patients.
For further information:
canSERV website: www.canserv.eu
Twitter: @canSERV_EU
LinkedIn: canSERV
Project coordination, BBMRI-ERIC:
Prof. Jens K. Habermann, Director General
Judit Balogh, Senior Project Manager
Press contact, ARTTIC Innovation GmbH:
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101058620.
The information and views set out in this press release are those of the author(s) and do not necessarily reflect the official opinion of the European Union. Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein.
ARTTIC Innovation GmbH has been advising research and innovation projects for more than 33 years. As project management and communication partner, we make sure that our projects run successfully and that project results and events are disseminated in the best possible way. ARTTIC is a subsidiary of the PNO Group, one of the largest consultancies for publicly funded projects in research and development. For more information, please visit www.arttic-innovation.de.
We take your privacy seriously. Click here to read our privacy policy. If you no longer wish to receive emails from us, please click below.
